The “journey,” in this instance, is brought on by ketamine, administered intravenously, as a treatment for mental health disorders, albeit one that has not yet been approved by the Food and Drug Administration.

The Philadelphia Inquirer wrote about SoundMind and interviewed our founder Dr. Hannah McLane. You can read some highlights in this post.

Philadelphia Magazine featured SoundMind and our founder Dr. Hannah McLane in a Q&A on psychedelic medicine in Philly! Some highlights from the interview are in the post.